血栓通治疗急性脑梗死76例临床研究

Clinical Research on Acute Cerebral Infarction Treated with Xueshuantong Injection

观察血栓通注射液治疗急性脑梗死临床疗效。 10 6例病人随机分为 2组 ,治疗组 76例在常规西医治疗基础上加用血栓通注射液 ,对照组 30例单纯采用西医常规治疗 ,同时观察了药物对急性脑梗死患者神经功能缺损程度及生活能力状态评分、血液流变学和血浆SOD、MDA含量等指标的影响 ,结果显示治疗组临床疗效明显优于对照组 ,同时治疗组能明显改善患者神经功能缺损程度及生活能力状态 ,血液流变学和自由基代谢等指标 ,与对照组比较 ,差异有显著性 (P <0 0 5或P <0 0 1) ,表明血栓通注射液组对急性脑梗死有较好治疗作用。

In order to evaluate clinical effects of Xueshuantong injection in treatment of acute cerebral infarction(ACI).106ACI cases were divided randomly into 2 groups,76 cases were treated with combination routine western medicine with Xueshuantong injection as treatment group,and 30 cases were administered with routine western medicine alone as control group.Meanwhile,the effects of the Xueshuantong injection on indexes of score of neurologic impairment and viability state,hemorheological parameters,the content of superoxide dismutase and malondialdehyde in the blood plasma in the patients with ACI were researched.Results showed that clinical therapeutic effect of treatment group was prior to that of control group,at the same time,Xueshuangtong injection could obviously improve indexes of score of neurologic impairment and viability state,hemorheological parameters,and free radical metabolism.Differences were very significant between two groups( P <0.05 or P <0.01).Above data indicated that Xueshuantong injection is an effective drug for acute cerebral infarction.